WO2008099853A1 - Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration - Google Patents

Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration Download PDF

Info

Publication number
WO2008099853A1
WO2008099853A1 PCT/JP2008/052356 JP2008052356W WO2008099853A1 WO 2008099853 A1 WO2008099853 A1 WO 2008099853A1 JP 2008052356 W JP2008052356 W JP 2008052356W WO 2008099853 A1 WO2008099853 A1 WO 2008099853A1
Authority
WO
WIPO (PCT)
Prior art keywords
tissue regeneration
periodontal tissue
agent
promoting periodontal
promoting
Prior art date
Application number
PCT/JP2008/052356
Other languages
French (fr)
Japanese (ja)
Inventor
Kazuo Nagai
Je-Tae Woo
Masato Ota
Takayuki Yonezawa
Toshiaki Teruya
Byung-Yoon Cha
Original Assignee
Kazuo Nagai
Je-Tae Woo
Masato Ota
Takayuki Yonezawa
Toshiaki Teruya
Byung-Yoon Cha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2007/052508 external-priority patent/WO2007091707A1/en
Application filed by Kazuo Nagai, Je-Tae Woo, Masato Ota, Takayuki Yonezawa, Toshiaki Teruya, Byung-Yoon Cha filed Critical Kazuo Nagai
Priority to JP2008558102A priority Critical patent/JP5317271B2/en
Publication of WO2008099853A1 publication Critical patent/WO2008099853A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

It is intended to provide an agent for promoting periodontal tissue regeneration which can shorten the time required for healing and has a high safety. Namely, a medicinal composition for treating periodontal diseases, an agent for promoting periodontal tissue regeneration and so on each comprising, as the active ingredient, at least one member selected from the group consisting of compounds represented by the following general formula (I), physiologically acceptable salts thereof and hydrates of the same are provided. Thus, it becomes possible to safely treat periodontal diseases within a short period of time.
PCT/JP2008/052356 2007-02-13 2008-02-13 Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration WO2008099853A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2008558102A JP5317271B2 (en) 2007-02-13 2008-02-13 Periodontal tissue regeneration promoting pharmaceutical composition and periodontal tissue regeneration promoting agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPPCT/JP2007/052508 2007-02-13
PCT/JP2007/052508 WO2007091707A1 (en) 2006-02-10 2007-02-13 Pharmaceutical composition for preventing and/or treating bone disease, functional food, health food, pharmaceutical preparation and tooth root-periodontal tissue formation promoting agent containing the composition

Publications (1)

Publication Number Publication Date
WO2008099853A1 true WO2008099853A1 (en) 2008-08-21

Family

ID=39705186

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/052356 WO2008099853A1 (en) 2007-02-13 2008-02-13 Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration

Country Status (1)

Country Link
WO (1) WO2008099853A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108771196A (en) * 2018-05-16 2018-11-09 广州馨杰添加剂有限公司 A kind of passionflower essence and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62148426A (en) * 1985-12-23 1987-07-02 Rooto Seiyaku Kk Remedy for periodontosis
JP2002104986A (en) * 2000-09-29 2002-04-10 Kobayashi Pharmaceut Co Ltd Periodontal disease medicine
JP2005053837A (en) * 2003-08-05 2005-03-03 Kao Corp Resorptive osteopathy prophylactic/therapeutic agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62148426A (en) * 1985-12-23 1987-07-02 Rooto Seiyaku Kk Remedy for periodontosis
JP2002104986A (en) * 2000-09-29 2002-04-10 Kobayashi Pharmaceut Co Ltd Periodontal disease medicine
JP2005053837A (en) * 2003-08-05 2005-03-03 Kao Corp Resorptive osteopathy prophylactic/therapeutic agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108771196A (en) * 2018-05-16 2018-11-09 广州馨杰添加剂有限公司 A kind of passionflower essence and preparation method thereof

Similar Documents

Publication Publication Date Title
WO2005075425A3 (en) Substituted bisarylurea derivatives as kinase inhibitors
BR0315580A (en) Methylene Urea Derivatives
WO2012142093A3 (en) 2'-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
WO2010088000A3 (en) Antifibrotic compounds and uses thereof
WO2009063202A3 (en) Use of crth2 antagonist compounds
PL2150530T3 (en) Substituted sulfonamide derivatives
GB0722077D0 (en) Compounds
WO2009109618A3 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
WO2008023258A8 (en) Piperidine derivatives
WO2009109616A8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
WO2007009720A3 (en) Prodrugs of pyrazoline compounds, their preparation and use as medicaments
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
WO2009003719A3 (en) Indane-amine derivatives, their preparation and use as medicaments
WO2009030952A3 (en) Phenylcarboxamide derivatives as inhibitors and effectors of the hedgehog pathway
WO2008116663A3 (en) Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
WO2009019708A3 (en) Pharmaceutical compositions and methods for the treatment of cancer
WO2007098967A3 (en) Imidazole compounds having pharmaceutical activity towards the sigma receptor
WO2008074833A3 (en) Compounds
MX2009005912A (en) Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments.
BRPI0507745A (en) substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, process for their preparation, medicaments and their uses
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
WO2008099853A1 (en) Medicinal composition for promoting periodontal tissue regeneration and agent for promoting periodontal tissue regeneration
WO2007059356A3 (en) Furfurylidene- pyrazolidines and their use as inhibitors of ubiquitin e1
WO2007115020A3 (en) Therapeutic prostaglandin compounds for the treatment of glaucoma

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08711214

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2008558102

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08711214

Country of ref document: EP

Kind code of ref document: A1